期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾移植术后巨细胞病毒感染的预防 被引量：3

Prophylaxis of Cytomegalovirus Infection Post Kidney Transplantation
原文传递
导出
摘要 巨细胞病毒(CMV)感染是肾移植术后常见的并发症之一,可直接影响移植肾/人的生存。CMV感染一旦发生,治疗难度大,因此预防是关键。本文针对肾移植术后CMV感染的危险因素、抗病毒药物分类以及预防方案的研究进展作一综述。 Cytomegalovirus（CMV） infection is one of the most common complications after kidney transplantation（KT）, which affects the survival of both graft and recipient. The key to treat CMV infection is prophylaxis, because it will be much more difficult once CMV infection occurs. In this review, we will summarize the risk factors of CMV infection, classification of antiviral drugs and progress of prophylaxis.
作者 王垒 黄康 彭贵主 叶啟发 WANG Lei;HUANG Kang;PENG Guizhu;YE Qifa(Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University Transplant Center of Wuhan University, ＆ Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071 , China;The 3rd Xiangya Hospital of Central South University ~ Research Center of National Health Ministry on Transplantation Medicine Engineering and Technology, Changsha 410013, China)
机构地区 武汉大学中南医院/武汉大学肝胆疾病研究院/武汉大学移植医学中心/移植医学技术湖北省重点实验室 中南大学湘雅三医院/卫生部移植医学工程技术研究中心
出处 《武汉大学学报（医学版）》 CAS 2017年第6期916-919,共4页 Medical Journal of Wuhan University
关键词 肾移植 巨细胞病毒感染 危险因素 抗病毒药物 预防 Kidney Transplantation Cytomegalovirus Infection Risk Factor Antiviral Drug Prophylaxis
分类号 K699.2 [历史地理—世界史]
  • 相关文献

参考文献2

二级参考文献21

  • 1Prichard MN, Kern ER. The search for new therapies for human eytomegalovirus infections[J]. Virus Res, 2011, 157 (2) :212-221.
  • 2Paya C, Humar A, Dominguez E, et al. Fficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients [J]. Am J Transplant, 2004, 4(4) :611-620.
  • 3H6rl MP, Schmitz M, Ivens K, et al. Opportunistic infections after renal transplantation[J]. Curr Opin Urol, 2002, 12(2): 115-123.
  • 4Sarmiento JM, Dockrell DH, Schwab TR, et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients[J]. Clin Transplant, 2000, 14(2) : 136-138.
  • 5Winston D J, Busuttil RW. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus- seronegative liver transplant recipients with cytomegalovirus- seropositive donors[J]. Transplantation, 2004, 77 (2), 305- 308.
  • 6Arichi N, Kishikawa H, Mitsui Y, et al. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center[J]. Transplant Proe, 2009, 41(1): 170- 172.
  • 7Neff RT, Jindal RM, Yoo DY, et al. Analysis of USRDS incidence and risk factors for Pneumocystis jiroveci pneumonia I-iT. Transplantation, 2009, 88(1):135-141.
  • 8YazakiH, Goto N, Uchida K, et a[. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant reeipients P. jiroveci is contagious to the susceptible host [J]. Transplantation, 2009, 88(3):380-385.
  • 9RabodonirinaM, Vanhems P, Couray-Targe S, et al. Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients[J]. Emerg Infect Dis, 2004, 10(10) : 1766-1773.
  • 10Li JY, Yong TY, Grove DI, et al. Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient [J]. Clin Exp Nephrol, 2009, t 3 (1) ; 9:2- 95.

共引文献9

同被引文献50

引证文献3

二级引证文献6

武汉大学学报（医学版）
2017年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部